Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation
Author:
Amit S. Kalgutkar,Deepak K. Dalvie,Jiri Aubrecht,Evan B. Smith,Stephanie L. Coffing,Jennifer R. Cheung,Chandra Vage,Mary E. Lame,Phoebe Chiang,Kim F. McClure,Tristan S. Maurer,Richard V. Coelho,Victor F. Soliman,Klaas Schildknegt
Publication:
Drug Metabolism and Disposition
© 2007 The American Society for Pharmacology and Experimental Therapeutics